AstraZeneca Resumes Vaccine Trial in Japan; U.S. Still on Hold

Bookmark
(Bloomberg) -- A vaccine trial for a front-runner Covid-19 shot from AstraZeneca Plc and the University of Oxford restarted in Japan after studies were halted globally last month when a U.K. partic...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.